Michael MacLean, Chief Financial and Chief Business Officer, joined Avidity Biosciences Inc in 2020. Mike brings more than 30 years of strategic financial leadership within life sciences and other industries to Avidity, with deep experience in funding biotechnology companies to advance novel therapies in the rare and orphan disease space. In addition, his past roles included working with growing global commercial teams to support multiple product launches.  Prior to Avidity, Mike served as Chief Financial Officer of Akcea Therapeutics, Inc., another company focused on RNA therapies, where he led the buildout of Akcea’s financial and commercial infrastructure, and also served as Chief Financial Officer of PureTech Health, plc. In addition, he held the position of Chief Accounting Officer of Biogen Inc. where he led the company’s worldwide finance operations. Mike currently serves as member of the board of directors at Verve Therapeutics.